Crispr Therapeutics shares owned by Raymond James Financial Services Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Raymond James Financial Services Advisors
from 13F filings
Historical chart of Raymond James Financial Services Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Raymond James Financial Services Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.9M | 62k | 46.98 |
| 2024-06-30 | $3.1M | 57k | 54.01 |
| 2024-03-31 | $3.1M | 46k | 68.16 |
| 2023-12-31 | $2.5M | 39k | 62.60 |
| 2023-09-30 | $1.5M | 33k | 45.39 |
| 2023-06-30 | $1.5M | 27k | 56.14 |
| 2023-03-31 | $1.3M | 29k | 45.23 |
| 2022-12-31 | $1.1M | 27k | 40.65 |
| 2022-09-30 | $1.7M | 26k | 65.33 |
| 2022-06-30 | $1.3M | 21k | 60.77 |
| 2022-03-31 | $1.5M | 24k | 62.75 |
| 2021-12-31 | $2.8M | 38k | 75.78 |
| 2021-09-30 | $3.3M | 30k | 111.94 |
| 2021-06-30 | $3.2M | 20k | 161.89 |
| 2021-03-31 | $3.4M | 28k | 121.84 |
| 2020-12-31 | $3.3M | 22k | 153.10 |
| 2020-09-30 | $1.3M | 15k | 83.64 |
| 2020-06-30 | $934k | 13k | 73.50 |
| 2020-03-31 | $459k | 11k | 42.41 |
| 2019-12-31 | $657k | 11k | 60.91 |
| 2019-09-30 | $374k | 9.1k | 41.04 |
| 2019-06-30 | $400k | 8.5k | 47.04 |
| 2019-03-31 | $264k | 7.4k | 35.67 |
| 2018-12-31 | $215k | 7.5k | 28.62 |
| 2018-09-30 | $577k | 13k | 44.34 |
| 2018-06-30 | $765k | 13k | 58.78 |
More positions owned by Raymond James Financial Services Advisors
Home Depot (HD)
View all positions for Raymond James Financial Services Advisors